Market Overview

UPDATE: Bank of America Raises PT on Acadia Healthcare Company on New Purchases

Related ACHC
Lifepoint Hospitals (LPNT) Worth Watching: Stock Gains 7.3% - Tale of the Tape
Tenet Healthcare Extends Contract with Humana to Drive Growth

In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Acadia Healthcare Company (NASDAQ: ACHC), and slightly raised the price target from $36.00 to $37.00.

In the report, Fischbeck noted, “On 4/5/13 ACHC announced it had reached an agreement to purchase two facilities, one in Puerto Rico and the other in Florida. The San Juan Capestrano Hospital in San Juan, Puerto Rico is licensed for 108 beds, with a certificate of need to build an additional 100 beds and produced ~$25m of revenue in 2012. The Tampa Florida facility is under construction with a scheduled open in Q1 2014 and will have 75 beds. The company will pay ~$92m plus construction costs for the Tampa facility. The purchase is scheduled for completion in 2Q13. With this news we are raising our 2013/14/15 estimates to $0.98/$1.23/$1.39 from $0.97/$1.20/$1.34, although we are being somewhat conservative around the opportunity for bed expansions at these sites and believe that there could be more upside in the out years. We are also raising our PO to $37 from $36.”

Acadia Healthcare Company closed on Thursday at $28.57.

Latest Ratings for ACHC

DateFirmActionFromTo
Jun 2014Raymond JamesMaintainsOutperform
Feb 2014Bank of AmericaMaintainsBuy
Jan 2014CitigroupDowngradesBuyNeutral

View More Analyst Ratings for ACHC
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Price Target Analyst Ratings

 

Related Articles (ACHC)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters